0A05 logo

Medacta GroupLSE:0A05 Stock Report

Market Cap CHF 2.7b
Share Price
CHF 138.80
My Fair Value
CHF 144
3.7% undervalued intrinsic discount
1Y14.0%
7D0.4%
Portfolio Value
View

Medacta Group (0A05) Stock Overview

Develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. More details

0A05 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends0/6

0A05 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Medacta Group SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medacta Group
Historical stock prices
Current Share PriceCHF 138.80
52 Week HighCHF 143.80
52 Week LowCHF 104.40
Beta1.11
1 Month Change5.95%
3 Month Change7.26%
1 Year Change13.96%
3 Year Change48.69%
5 Year Change65.56%
Change since IPO45.62%

Recent News & Updates

Recent updates

Shareholder Returns

0A05GB Medical EquipmentGB Market
7D0.4%1.5%1.1%
1Y14.0%-1.5%7.4%

Return vs Industry: 0A05 exceeded the UK Medical Equipment industry which returned -1.5% over the past year.

Return vs Market: 0A05 exceeded the UK Market which returned 7.4% over the past year.

Price Volatility

Is 0A05's price volatile compared to industry and market?
0A05 volatility
0A05 Average Weekly Movement3.1%
Medical Equipment Industry Average Movement6.3%
Market Average Movement5.0%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0A05 has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0A05's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19581,907Francesco Siccardiwww.medacta.com

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Medacta Group SA Fundamentals Summary

How do Medacta Group's earnings and revenue compare to its market cap?
0A05 fundamental statistics
Market capCHF 2.75b
Earnings (TTM)CHF 67.76m
Revenue (TTM)CHF 549.07m
40.9x
P/E Ratio
5.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0A05 income statement (TTM)
Revenue€590.58m
Cost of Revenue€191.14m
Gross Profit€399.44m
Other Expenses€326.55m
Earnings€72.89m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Sep 08, 2025

Earnings per share (EPS)3.66
Gross Margin67.64%
Net Profit Margin12.34%
Debt/Equity Ratio51.1%

How did 0A05 perform over the long term?

See historical performance and comparison

Dividends

0.5%
Current Dividend Yield
20%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/23 18:51
End of Day Share Price 2025/07/23 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medacta Group SA is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Christoph GretlerCredit Suisse
David AdlingtonJ.P. Morgan